KFF Health News’ ‘What the Health?’: The long road to reining in short-term plans

The CDC’s vac­cine ad­vi­sors on Fri­day af­ter­noon vot­ed 11-1 to rec­om­mend Pfiz­er’s ma­ter­nal RSV vac­cine for preg­nant peo­ple at 32 to 36 weeks of ges­ta­tion

In No­vem­ber, EQRx pub­licly gave up on the fi­nal pieces of its low-cost med­i­cines ap­proach. But in a re­cent fi­nan­cial fil­ing, the com­pa­ny re­vealed that

A group of pay­ers has ac­cused John­son & John­son of de­fraud­ing the US Patent and Trade­mark Of­fice in a scheme to curb Ste­lara com­pe­ti­tion, ac­cord­ing